
| Pair Name | Paeonol, Paclitaxel | ||
| Phytochemical Name | Paeonol (PubChem CID: 11092 ) | ||
| Anticancer drug Name | Paclitaxel (PubChem CID: 36314 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Paeonol, Paclitaxel | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | transgelin 2 | KEGG ID N.A. |
| Down-regulation | Expression | P-gp | KEGG ID N.A. | |
| Down-regulation | Expression | MRP1 | KEGG ID N.A. | |
| Down-regulation | Expression | BCRP | KEGG ID N.A. | |
| In Vitro Model | MCF-7/PTX | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_C5RS |
| Result | These results not only provide insight into the potential application of paeonol to the reversal of paclitaxel resistance, thus facilitating the sensitivity of breast cancer chemotherapy, but also highlight a potential role of transgelin 2 in the development of paclitaxel resistance in breast cancer. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2. Phytomedicine. 2014;21(7):984-991. doi:10.1016/j.phymed.2014.02.012 | Click |